IXICO PLC PHYOF:Grey Market

RT Quote | Exchange | USD
Last | 03/01/21 EST
1.29UNCH (UNCH)
52 week range
0.67 - 1.47

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.29
  • 52 Week High1.47
  • 52 Week High Date11/23/20
  • 52 Week Low0.67
  • 52 Week Low Date04/03/20
  • Market Cap57.48M
  • Shares Out47.09M
  • 10 Day Average Volume1,000
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.03
  • P/E (TTM)49.37
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest IXICO PLC News

There is no recent news for this security.

Latest PHYOF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker. Assessa is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes. mehealth is an...
Charles Spicer
Non-Executive Chairman
Giulio Cerroni
Chief Executive Officer
Grant Nash
Chief Financial Officer
Address
4th Fl, Griffin Court, 15 Long Lane
London
EC1A 9PN
United Kingdom